TATTON expansion cohorts: A phase Ib study of osimertinib plus savolitinib in patients (pts) with EGFR-mutant, MET-positive NSCLC following disease progression on a prior EGFR-TKI Meeting Abstract
| Authors: | Han, J. Y.; Sequist, L. V.; Ahn, M. J.; Cho, B. C.; Yu, H.; Kim, S. W.; Yang, J. C. H.; Lee, J. S.; Su, W. C.; Kowalski, D.; Orlov, S.; Cantarini, M.; Verheijen, R. B.; Mellemgaard, A.; Frewer, P.; Ou, X.; Oxnard, G. |
| Abstract Title: | TATTON expansion cohorts: A phase Ib study of osimertinib plus savolitinib in patients (pts) with EGFR-mutant, MET-positive NSCLC following disease progression on a prior EGFR-TKI |
| Meeting Title: | 2019 ESMO Asia Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2019 Nov 22-24 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-11-01 |
| Start Page: | mdz446.001 |
| Language: | English |
| ACCESSION: | WOS:000503487700538 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz446.001 |
| Notes: | Meeting Abstract: LBA2 -- Appears on pages ix196-ix197 of the abstract book -- Source: Wos |
